Rigacci, Luigi <br/><br/>
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)ħrituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.  [electronic resource] 

 -  Cancer  Oct 2010 
 - 4573-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.25216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cytarabine--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Recurrence<br/>Rituximab<br/>Salvage Therapy<br/>Treatment Outcome